AmCad BioMed Corporation (AmCad)

AmCad BioMed Corporation (AmCad) was founded in 2008 and was listed on Taipei Exchange in March of 2015 (Ticker: 4188). AmCad is dedicated to developing innovative Computer-Assisted Detection and Diagnosis (CAD) devices. Moreover, AmCad is committed to developing unique products that assist medical professionals in making more accurate early diagnoses. By integrating AI with innovative hardware solutions, we aim to solve long-standing unmet medical needs. We are bolstering clinicians’ expertise with AI-driven technology. Our patented algorithms provide medical professionals detailed quantification and visualization of sonographic characteristics.